MA
MCF Advisors Portfolio holdings
AUM
$1.51B
1-Year Return
11.12%
This Quarter Return
-0.73%
1 Year Return
+11.12%
3 Year Return
+41.11%
5 Year Return
+65.13%
10 Year Return
+108.06%
AUM
$1.42B
AUM Growth
-$1.01M
(-0.07%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
67.23%
Holding
1,059
New
54
Increased
253
Reduced
201
Closed
67
Top Buys
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$23.9M |
| 2 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
$9.27M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$5.21M |
| 4 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
$1.96M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$1.5M |
Sector Composition
| 1 | Technology | 4.43% |
| 2 | Financials | 2.69% |
| 3 | Healthcare | 1.3% |
| 4 | Industrials | 1.24% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Ferrari
RACE
$87.1B
| $74.8K | 0.01% |
176
| – | – |
|
352
SPDR Gold Trust
GLD
$112B
| $72.2K | 0.01% |
298
-21
| -7% | -$5.09K |
|
353
Watsco
WSO
$16.6B
| $71.2K | 0.01% |
150
+35
| +30% | +$16.6K |
|
354
Community Trust Bancorp
CTBI
$1.06B
| $70.1K | ﹤0.01% |
1,311
| – | – |
|
355
Vertex Pharmaceuticals
VRTX
$102B
| $70.1K | ﹤0.01% |
174
| – | – |
|
356
American Tower
AMT
$92.9B
| $69.9K | ﹤0.01% |
378
-38
| -9% | -$7.03K |
|
357
Schwab Fundamental International Small Company Index ETF
FNDC
$3.01B
| $69.5K | ﹤0.01% |
2,036
| – | – |
|
358
Linde
LIN
$220B
| $69.2K | ﹤0.01% |
165
+25
| +18% | +$10.5K |
|
359
Vanguard S&P 500 Value ETF
VOOV
$5.69B
| $68.8K | ﹤0.01% |
373
| – | – |
|
360
Kellanova
K
$27.8B
| $66.6K | ﹤0.01% |
822
+404
| +97% | +$32.7K |
|
361
United Therapeutics
UTHR
$18.1B
| $66.3K | ﹤0.01% |
188
| – | – |
|
362
Artisan Partners
APAM
$3.26B
| $66.2K | ﹤0.01% |
1,538
+638
| +71% | +$27.5K |
|
363
Welltower
WELL
$112B
| $66K | ﹤0.01% |
524
| – | – |
|
364
Vanguard S&P 500 Growth ETF
VOOG
$19.3B
| $65.9K | ﹤0.01% |
180
| – | – |
|
365
S&P Global
SPGI
$164B
| $65.8K | ﹤0.01% |
132
| – | – |
|
366
Novo Nordisk
NVO
$245B
| $64.9K | ﹤0.01% |
755
| – | – |
|
367
VanEck Junior Gold Miners ETF
GDXJ
$7B
| $64.6K | ﹤0.01% |
1,511
-256
| -14% | -$10.9K |
|
368
Invesco S&P 500 Low Volatility ETF
SPLV
$7.99B
| $64K | ﹤0.01% |
915
+775
| +554% | +$54.2K |
|
369
Allstate
ALL
$53.1B
| $63.8K | ﹤0.01% |
330
| – | – |
|
370
CrowdStrike
CRWD
$105B
| $63.6K | ﹤0.01% |
186
+6
| +3% | +$2.05K |
|
371
UGI
UGI
$7.43B
| $63.5K | ﹤0.01% |
2,250
| – | – |
|
372
Vanguard Russell 1000 ETF
VONE
$6.67B
| $63.5K | ﹤0.01% |
+238
| New | +$63.5K |
|
373
Sysco
SYY
$39.4B
| $62.5K | ﹤0.01% |
818
-61
| -7% | -$4.66K |
|
374
Cencora
COR
$56.7B
| $62.5K | ﹤0.01% |
278
| – | – |
|
375
iShares MSCI USA Quality Factor ETF
QUAL
$54.3B
| $62.2K | ﹤0.01% |
349
-210
| -38% | -$37.4K |
|